Cleared Traditional

F499 DELUXE ELECTRIC TOOTH BRUSH W/ STAND (K920644) - FDA 510(k) Clearance

Class I Dental device.

K920644 · Fairform Mfg., Co., Ltd. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1992
Decision
107d
Days
Class 1
Risk

K920644 is an FDA 510(k) clearance for the F499 DELUXE ELECTRIC TOOTH BRUSH W/ STAND. Classified as Toothbrush, Powered (product code JEQ), Class I - General Controls.

Submitted by Fairform Mfg., Co., Ltd. (San Po Kong, Kowloon, HK). The FDA issued a Cleared decision on May 29, 1992 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.6865 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Fairform Mfg., Co., Ltd. devices

Submission Details

510(k) Number K920644 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 1992
Decision Date May 29, 1992
Days to Decision 107 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 127d · This submission: 107d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JEQ Toothbrush, Powered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.6865
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.